Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Adamis Pharmaceuticl (ADMP)

Adamis Pharmaceuticl (ADMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 61,870
  • Shares Outstanding, K 149,733
  • Annual Sales, $ 2,210 K
  • Annual Income, $ -45,830 K
  • 60-Month Beta 1.28
  • Price/Sales 30.35
  • Price/Cash Flow N/A
  • Price/Book 4.22
Trade ADMP with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings -0.07 on 05/16/22
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 207.73% ( +63.50%)
  • Historical Volatility 92.36%
  • IV Percentile 87%
  • IV Rank 18.25%
  • IV High 876.12% on 04/22/22
  • IV Low 58.55% on 12/23/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 292
  • Volume Avg (30-Day) 491
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 34,134
  • Open Int (30-Day) 31,315

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.04
  • Number of Estimates 2
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3118 +30.50%
on 05/12/22
0.4999 -18.60%
on 05/16/22
-0.0381 (-8.56%)
since 04/22/22
3-Month
0.3118 +30.50%
on 05/12/22
0.7345 -44.60%
on 03/01/22
-0.1792 (-30.57%)
since 02/23/22
52-Week
0.3118 +30.50%
on 05/12/22
1.4800 -72.51%
on 10/18/21
-0.3962 (-49.33%)
since 05/21/21

Most Recent Stories

More News
Adamis Pharmaceuticals Announces Leadership Transition to Support New Phase of Innovation and Growth

David J. Marguglio, Co-Founder and Chief Business Officer, Appointed President and CEO Dennis J. Carlo, Ph.D., Has Retired as Both CEO and Board Director ...

ADMP : 0.4069 (-1.52%)
Adamis Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ...

ADMP : 0.4069 (-1.52%)
Adamis Pharmaceuticals Schedules First Quarter 2022 Financial Results Conference Call and Business Update

SAN DIEGO, May 09, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing...

ADMP : 0.4069 (-1.52%)
5 Winning Stocks to Land on the Overlooked Rising P/E Trick

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

POOL : 404.76 (-0.20%)
GIII : 22.60 (-1.09%)
SHOO : 34.27 (-2.11%)
ADMP : 0.4069 (-1.52%)
Adamis Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Corporate Update

Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ...

ADMP : 0.4069 (-1.52%)
US WorldMeds and Adamis Pharmaceuticals Announce U.S. Launch of ZIMHI™ Naloxone Product

High-Dose Naloxone Now Available to Help Combat the Growing Epidemic of Overdose Deaths...

ADMP : 0.4069 (-1.52%)
Acutus Medical, Inc. (AFIB) Reports Q4 Loss, Tops Revenue Estimates

Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of -8.70% and 1.44%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

AFIB : 0.7422 (-6.47%)
ADMP : 0.4069 (-1.52%)
Infinity Pharmaceuticals (INFI) Reports Q4 Loss, Tops Revenue Estimates

Infinity (INFI) delivered earnings and revenue surprises of 7.14% and 10.54%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

INFI : 0.6199 (-1.07%)
ADMP : 0.4069 (-1.52%)
Ayala Pharmaceuticals, Inc. (AYLA) Reports Q4 Loss, Tops Revenue Estimates

Ayala Pharmaceuticals, Inc. (AYLA) delivered earnings and revenue surprises of 1.49% and 32.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the...

AYLA : 2.07 (-1.43%)
ADMP : 0.4069 (-1.52%)
Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call and Business Update

SAN DIEGO, March 24, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and...

ADMP : 0.4069 (-1.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged engages in the research, development, and commercialization of prescription medicines for the treatment of viral infections. Adamis Pharmaceuticals is composed of two wholly owned...

See More

Key Turning Points

3rd Resistance Point 0.4445
2nd Resistance Point 0.4322
1st Resistance Point 0.4196
Last Price 0.4069
1st Support Level 0.3947
2nd Support Level 0.3824
3rd Support Level 0.3698

See More

52-Week High 1.4800
Fibonacci 61.8% 1.0337
Fibonacci 50% 0.8959
Fibonacci 38.2% 0.7581
Last Price 0.4069
52-Week Low 0.3118

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar